NEWS

Aug 08, 2014
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes

Aug 06, 2014
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes

Aug 05, 2014
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance

Aug 05, 2014
Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.


EVENTS

Jazz Pharmaceuticals at Canaccord Genuity Growth Conference
Aug 13, 2014

Q2 2014 Jazz Pharmaceuticals Earnings Conference Call
Aug 05, 2014

Jazz Pharmaceuticals Agreement to acquire rights to defibrotide in the Americas
Jul 02, 2014

Jazz Pharmaceuticals at Goldman Sachs Healthcare Conference
Jun 10, 2014

Jazz Pharmaceuticals Conference Call at 2014 SLEEP Meeting
Jun 02, 2014

Jazz Pharmaceuticals at UBS Global Healthcare Conference
May 20, 2014

Q1 2014 Jazz Pharmaceuticals Earnings Conference Call
May 08, 2014

Jazz Pharmaceuticals at Barclays Healthcare Conference
Mar 12, 2014

Jazz Pharmaceuticals at Cowen Health Care Conference
Mar 05, 2014

Q4 2013 Jazz Pharmaceuticals Earnings Conference Call
Feb 25, 2014

Jazz Pharmaceuticals at JPMorgan Healthcare Conference
Jan 13, 2014

Jazz Pharmaceuticals Conference Call to discuss Rights to ADX-N05 Acquisition from Aerial Biopharma
Jan 13, 2014

Jazz Pharmaceuticals Conference Call to discuss its Definitive Agreement to Acquire Gentium S.p.A
Dec 19, 2013

Jazz Pharmaceuticals at Piper Jaffray Healthcare Conference
Dec 03, 2013

Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients’ lives. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success.

BREAKING GROUND IN IRELAND

Jazz Pharmaceuticals has commenced construction of a manufacturing and development facility in Ireland

Read more

NEW: PRODUCT UPDATE

Jazz Pharmaceuticals and Gentium Announce European Commercial Launch of First Approved Life-saving Treatment for Severe Hepatic Veno-Occlusive Disease

Read more

MEDICINE ABUSE PROJECT

As part of our commitment to patient and public safety, we’re proud to be supporting the Medicine Abuse Project.

Visit the Medicine Abuse Project site

PRODUCT UPDATE

Jazz Pharmaceuticals announced U.S. commercial availability of additional product in its psychiatry portfolio.

Read more